Show simple item record

Identification of the first structurally validated covalent ligands of the small GTPase RAB27A

dc.contributor.authorJamshidiha, M
dc.contributor.authorLanyon-Hogg, T
dc.contributor.authorSutherell, CL
dc.contributor.authorCraven, GB
dc.contributor.authorTersa, M
dc.contributor.authorDe Vita, E
dc.contributor.authorBrustur, D
dc.contributor.authorPérez-Dorado, I
dc.contributor.authorHassan, S
dc.contributor.authorPetracca, R
dc.contributor.authorMorgan, RM
dc.contributor.authorSanz-Hernández, M
dc.contributor.authorNorman, JC
dc.contributor.authorArmstrong, A
dc.contributor.authorMann, DJ
dc.contributor.authorCota, E
dc.contributor.authorTate, EW
dc.date.accessioned2023-12-11T11:16:50Z
dc.date.available2023-12-11T11:16:50Z
dc.date.issued2022-02-23
dc.identifier.issn2040-2503
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/92786
dc.format.extent150 - 155
dc.publisherRoyal Society of Chemistry (RSC)en_US
dc.relation.ispartofRSC Medicinal Chemistry
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectCanceren_US
dc.subjectBiotechnologyen_US
dc.subject2.1 Biological and endogenous factorsen_US
dc.subject2 Aetiologyen_US
dc.subjectCanceren_US
dc.titleIdentification of the first structurally validated covalent ligands of the small GTPase RAB27Aen_US
dc.typeArticleen_US
dc.identifier.doi10.1039/d1md00225b
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.volume13en_US
qmul.funderTargeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer::European Commissionen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States